Back
International Bio Funders Compact: Integrating Biosecurity into Life Science Research Funding
webCredibility Rating
4/5
High(4)High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: Nuclear Threat Initiative
Relevant to AI safety audiences interested in how coordination mechanisms and funding compacts are structured for catastrophic risk reduction, as analogous models may apply to AI safety funding coordination.
Metadata
Importance: 45/100press releasenews
Summary
The Bio Funders Compact is an initiative by NTI and partner organizations to coordinate philanthropic and institutional funding for biosecurity research. It aims to align funders around shared priorities to reduce biological risks, including those from engineered pathogens and dual-use research. The compact represents a coordination effort to fill critical gaps in biosecurity funding.
Key Points
- •Brings together funders to coordinate investments in biosecurity and pandemic preparedness research
- •Addresses gaps in funding for research that reduces biological risks, including engineered and natural threats
- •Represents a governance and coordination mechanism for the biosecurity philanthropic community
- •Reflects growing recognition that fragmented funding hampers effective biosecurity progress
- •NTI (Nuclear Threat Initiative) serves as a convening organization for this multi-stakeholder effort
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| NTI | bio (Nuclear Threat Initiative - Biological Program) | Organization | 60.0 |
Cached Content Preview
HTTP 200Fetched Apr 7, 20267 KB
Bio Funders Compact | Advancing Biosecurity in Research
Close
News
Jun 20, 2024
International Bio Funders Compact to Integrate Biosecurity into Life Science Research Funding
Share
-->
Twitter
Facebook
Linkedin
Email
Links & Downloads
International Bio Funders Compact
The Nuclear Threat Initiative (NTI), in partnership with the Coalition for Epidemic Preparedness Innovations (CEPI), launched the international Bio Funders Compact at the 2024 Global Health Security Conference in Sydney, Australia. The Compact incorporates biosecurity into the bioscience research funding process to safeguard life science research from accidental or intentional misuse. Joining NTI and CEPI as founding signatories are Sentinel Bio — a new philanthropic fund launching soon — and the Global Health Security Fund .
The world is experiencing a 21st century bioscience and biotechnology revolution driven by rapid technological advances and accelerated by artificial intelligence. These advances offer significant potential benefits for promoting human health and pandemic preparedness, fostering economic development, and guarding against climate change. However, the accelerating global development of life science research and biotechnology is also contributing to growing risks of accidents or deliberate misuse.
Life science funders and investors in government, philanthropy, and the private sector hold significant leverage at the beginning of the bioscience and biotechnology research and development lifecycle. However, many funders do not conduct rigorous biosecurity reviews as part of their decision-making processes, and there are no agreed-upon best practices for doing so. The Bio Funders Compact will address this critical gap.
“The Bio Funders Compact will bring together global funders of life science research who are committed to safeguarding the tools of modern bioscience and biotechnology,” said Jaime Yassif, Ph.D., Vice President for Global Biological Policy and Programs at NTI. “We are inspired by the funders who are stepping forward today to make this shared commitment to prioritizing biosafety and biosecurity in their work. This is an important step forward for guarding against future pandemic risks and protecting populations around the world.”
“I am very pleased to have signed the Bio Funders Compact this week on behalf of CEPI. It demonstrates our commitment as a research funder to promote safe, secure, and responsible investments in research against epidemic and pandemic threats. I am proud that CEPI is one of the first signatories to this important effort that will strengthen our collective capacity to safeguard life-saving research,” said Dr. Richard Hatchett, CEO of CEPI. “Enabled by generous support from Global Affairs Canada, CEPI h
... (truncated, 7 KB total)Resource ID:
0b4c7f58800bfa3e | Stable ID: sid_hzYsAaMBcG